Literature DB >> 20031443

Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications.

Frederic Leblond1, Scott C Davis, Pablo A Valdés, Brian W Pogue.   

Abstract

Fluorescence sampling of cellular function is widely used in all aspects of biology, allowing the visualization of cellular and sub-cellular biological processes with spatial resolutions in the range from nanometers up to centimeters. Imaging of fluorescence in vivo has become the most commonly used radiological tool in all pre-clinical work. In the last decade, full-body pre-clinical imaging systems have emerged with a wide range of utilities and niche application areas. The range of fluorescent probes that can be excited in the visible to near-infrared part of the electromagnetic spectrum continues to expand, with the most value for in vivo use being beyond the 630 nm wavelength, because the absorption of light sharply decreases. Whole-body in vivo fluorescence imaging has not yet reached a state of maturity that allows its routine use in the scope of large-scale pre-clinical studies. This is in part due to an incomplete understanding of what the actual fundamental capabilities and limitations of this imaging modality are. However, progress is continuously being made in research laboratories pushing the limits of the approach to consistently improve its performance in terms of spatial resolution, sensitivity and quantification. This paper reviews this imaging technology with a particular emphasis on its potential uses and limitations, the required instrumentation, and the possible imaging geometries and applications. A detailed account of the main commercially available systems is provided as well as some perspective relating to the future of the technology development. Although the vast majority of applications of in vivo small animal imaging are based on epi-illumination planar imaging, the future success of the method relies heavily on the design of novel imaging systems based on state-of-the-art optical technology used in conjunction with high spatial resolution structural modalities such as MRI, CT or ultrasound. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2009        PMID: 20031443      PMCID: PMC3678966          DOI: 10.1016/j.jphotobiol.2009.11.007

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  169 in total

1.  Analytical solutions for time-resolved fluorescence lifetime imaging in a turbid medium such as tissue.

Authors:  D Hattery; V Chernomordik; M Loew; I Gannot; A Gandjbakhche
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2001-07       Impact factor: 2.129

2.  Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry.

Authors:  David R Vera; David J Hall; Carl K Hoh; Pascal Gallant; Laura M McIntosh; Robert F Mattrey
Journal:  Nucl Med Biol       Date:  2005-10       Impact factor: 2.408

3.  Time-resolved scanning system for double reflectance and transmittance fluorescence imaging of diffusive media.

Authors:  Marco Brambilla; Lorenzo Spinelli; Antonio Pifferi; Alessandro Torricelli; Rinaldo Cubeddu
Journal:  Rev Sci Instrum       Date:  2008-01       Impact factor: 1.523

4.  A time domain fluorescence tomography system for small animal imaging.

Authors:  Anand T N Kumar; Scott B Raymond; Andrew K Dunn; Brian J Bacskai; David A Boas
Journal:  IEEE Trans Med Imaging       Date:  2008-08       Impact factor: 10.048

5.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

6.  Fluorescence lifetime imaging system for in vivo studies.

Authors:  Moinuddin Hassan; Jason Riley; Victor Chernomordik; Paul Smith; Randall Pursley; Sang Bong Lee; Jacek Capala; Amir H Gandjbakhche
Journal:  Mol Imaging       Date:  2007 Jul-Aug       Impact factor: 4.488

7.  Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice.

Authors:  Sachin Patwardhan; Sharon Bloch; Samuel Achilefu; Joseph Culver
Journal:  Opt Express       Date:  2005-04-04       Impact factor: 3.894

8.  Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo.

Authors:  Severine Wack; Amor Hajri; Francine Heisel; Malgorzata Sowinska; Cedric Berger; Maurice Whelan; Jacques Marescaux; Marc Aprahamian
Journal:  Mol Ther       Date:  2003-06       Impact factor: 11.454

9.  A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases.

Authors:  Yukihiro Hama; Yasuteru Urano; Yoshinori Koyama; Andrew J Gunn; Peter L Choyke; Hisataka Kobayashi
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

10.  Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.

Authors:  Cynthia S Snyder; Sharmeela Kaushal; Yuko Kono; Hop S Tran Cao; Robert M Hoffman; Michael Bouvet
Journal:  BMC Cancer       Date:  2009-04-08       Impact factor: 4.430

View more
  173 in total

1.  Temperature-modulated fluorescence tomography in a turbid media.

Authors:  Yuting Lin; Linden Bolisay; Michael Ghijsen; Tiffany C Kwong; Gultekin Gulsen
Journal:  Appl Phys Lett       Date:  2012-02-15       Impact factor: 3.791

Review 2.  Implicit and explicit prior information in near-infrared spectral imaging: accuracy, quantification and diagnostic value.

Authors:  Brian W Pogue; Scott C Davis; Frederic Leblond; Michael A Mastanduno; Hamid Dehghani; Keith D Paulsen
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

3.  A high throughput capillary electrophoresis method to obtain pharmacokinetics and quality attributes of a therapeutic molecule in circulation.

Authors:  Reema Piparia; David Ouellette; W Blaine Stine; Christine Grinnell; Edit Tarcsa; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

4.  Quantitative fluorescence tomography using a trimodality system: in vivo validation.

Authors:  Yuting Lin; William C Barber; Jan S Iwanczyk; Werner W Roeck; Orhan Nalcioglu; Gultekin Gulsen
Journal:  J Biomed Opt       Date:  2010 Jul-Aug       Impact factor: 3.170

5.  Fast single photon avalanche photodiode-based time-resolved diffuse optical tomography scanner.

Authors:  Ying Mu; Mark Niedre
Journal:  Biomed Opt Express       Date:  2015-08-26       Impact factor: 3.732

6.  Implementation of a new scanning method for high-resolution fluorescence tomography using thermo-sensitive fluorescent agents.

Authors:  Farouk Nouizi; Tiffany C Kwong; Jaedu Cho; Yuting Lin; Uma Sampathkumaran; Gultekin Gulsen
Journal:  Opt Lett       Date:  2015-11-01       Impact factor: 3.776

7.  Multiple-pulse pumping for enhanced fluorescence detection and molecular imaging in tissue.

Authors:  Ryan M Rich; Ignacy Gryczynski; Rafal Fudala; Julian Borejdo; Dorota L Stankowska; Raghu R Krishnamoorthy; Sangram Raut; Badri P Maliwal; Dmytro Shumilov; Hung Doan; Zygmunt Gryczynski
Journal:  Methods       Date:  2013-08-29       Impact factor: 3.608

Review 8.  Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Authors:  Y Ardeshirpour; V Chernomordik; J Capala; M Hassan; R Zielinsky; G Griffiths; S Achilefu; P Smith; A Gandjbakhche
Journal:  Technol Cancer Res Treat       Date:  2011-12

9.  Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research.

Authors:  Yidong Yang; Ken Kang-Hsin Wang; Sohrab Eslami; Iulian I Iordachita; Michael S Patterson; John W Wong
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

10.  Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule.

Authors:  Michael Dobosz; Ute Haupt; Werner Scheuer
Journal:  MAbs       Date:  2016-09-23       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.